China’s Race for First Covid-19 Vaccine Raises Safety Questions

The video discusses the disparity in information between Chinese and Western COVID-19 vaccine developers. It highlights concerns about the safety and efficacy of Chinese vaccines, which are being widely distributed under emergency use authorizations without sufficient monitoring. The video contrasts this with the more transparent approach of Western developers. It also addresses the risks associated with limited follow-up on vaccine recipients and the potential for unreported adverse reactions.

In what ways are the safety and efficacy of the Chinese vaccines being questioned by experts?

What are the potential risks associated with the lack of monitoring in the emergency use of vaccines?